Our results indicated that NOE and DTX at dosages of 500 mg/kg and 2.5 mg/kg, respectively, reduced the relative expression of α-SMA contrast to the asthma group (p < 0.05) (Figure 4(c)). This evidence concerns the gene ACTA1 and asthma.